Very high quantitative tumor HER2 content and outcome in early breast cancer.
Joensuu H, Sperinde J, Leinonen M, Huang W, Weidler J, Bono P, Kataja V, Kokko R, Turpeenniemi-Hujanen T, Jyrkkiö S, Isola J, Kellokumpu-Lehtinen PL, Paquet A, Lie Y, Bates M.
Joensuu H, et al.
Ann Oncol. 2011 Sep;22(9):2007-2013. doi: 10.1093/annonc/mdq710. Epub 2011 Feb 1.
Ann Oncol. 2011.
PMID: 21285132
Free article.
Clinical Trial.